Skip to main content
. 2015 Jul 29;56(5):1338–1344. doi: 10.3349/ymj.2015.56.5.1338

Table 3. Univariate and Multivariate Analysis among Groups.

Univariate Multivariate
OR 95% CI p value OR 95% CI p value
FLT vs. PTC
 TSH>2.50 µIU/mL 4.462 2.169-9.178 <0.001
 Tg-Ab positivity 9.118 4.191-19.841 <0.001 3.036 1.060-8.696 0.039
 TPO-Ab positivity 4.136 2.010-8.514 <0.001
 Taller than wider 0.815 0.421-1.576 0.543
 Absence of calcification 2.897 1.340-6.261 0.007 3.781 1.182-12.097 0.025
 Presence of DTD pattern 36.231 14.192-92.500 <0.001 24.519 8.597-69.925 <0.001
AH vs. PTC
 TSH>2.50 µIU/mL 0.917 0.404-2.077 0.835
 Tg-Ab positivity 0.735 0.283-1.909 0.527
 TPO-Ab positivity 0.425 0.161-1.122 0.084 0.427 0.157-1.163 0.096
 Taller than wider 0.292 0.146-0.587 0.001 0.288 0.140-0.590 0.001
 Absence of calcification 0.700 0.367-1.336 0.280
 Presence of DTD pattern 1.145 0.386-3.395 0.808

FLT, focal lymphocytic thyroiditis; PTC, papillary thyroid cancer; AH, adenomatous hyperplasia; TSH, thyrotropin; Tg-Ab, thyroglobulin antibody; TPO-Ab, thyroid peroxidase antibody; DTD pattern, "diffuse thyroid disease" pattern on US; OR, odds ratio; CI, confidence interval; US, ultrasound.